NCT04758377

Brief Summary

The study is designed to determine whether hemorrhage within the injured spinal cord is influenced by mean arterial pressure (MAP) augmentation with vasopressors and by venous thromboembolism (VTE) prophylaxis with anticoagulants in the first two weeks following a traumatic spinal cord injury (tSCI).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 6, 2021

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

February 12, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 17, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

3.3 years

First QC Date

February 12, 2021

Last Update Submit

June 30, 2023

Conditions

Keywords

vasopressorsmagnetic resonance imaging

Outcome Measures

Primary Outcomes (4)

  • Hemorrhage Quantification 1

    Area of hematoma

    Serial MRI assessments: Injury to 2 weeks post injury

  • Hemorrhage Quantification 2

    Vertical length of hematoma and vertical length of cord edema

    Serial MRI assessments: Injury to 2 weeks post injury

  • Hemorrhage Quantification 3

    The point of maximum cord compression vertebral level and anatomic point of maximum cord compression vertebral sublevel

    Serial MRI assessments: Injury to 2 weeks post injury

  • Hemorrhage Quantification 4

    Vertical length of cord edema rostral to maximum compression and vertical length of cord edema caudal to maximum compression.

    Serial MRI assessments: Injury to 2 weeks post injury

Secondary Outcomes (2)

  • Hemodynamic Management Assessment 1

    Injury to 2 weeks post injury

  • Hemodynamic Management Assessment 2

    Injury to 2 weeks post injury

Other Outcomes (1)

  • Neurologic Assessments

    Injury to 6 months post injury

Study Arms (1)

Arm 1

EXPERIMENTAL

Serial MRI scans of patients with acute cervical SCI to quantify hemorrhage.

Procedure: Magnetic resonance imaging (MRI)

Interventions

Serial MRI scans of patients with acute cervical SCI to quantify hemorrhage.

Arm 1

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute tSCI injury involving bony spinal levels between C0 and T1
  • Baseline Asia Impairment Scale (AIS) grade of A, B, or C
  • Admission to study site within 24 hours of injury
  • Male or female age 19 or older
  • Able and willing to provide informed consent

You may not qualify if:

  • Pathological fracture due to metabolic condition or neoplasia
  • Spinal cord injury due to infection
  • Presence of pacemaker, aneurysm clip or other device which is a contraindication to MRI
  • BMI \> 40 and unable to fit within the MRI scanner
  • Multiple life threatening injuries (ISS \>16) that make transport to MRI not in the patient's best interest
  • Any condition that, at the time of admission, prevents a complete ISNCSCI assessment from being performed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vancouver General Hospital

Vancouver, British Columbia, Canada

RECRUITING

MeSH Terms

Interventions

Magnetic Resonance Spectroscopy

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Brian Kwon, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 12, 2021

First Posted

February 17, 2021

Study Start

February 6, 2021

Primary Completion

June 1, 2024

Study Completion

June 1, 2025

Last Updated

July 3, 2023

Record last verified: 2023-06

Locations